Page last updated: 2024-08-25

adriamycinol and pixantrone

adriamycinol has been researched along with pixantrone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chello, M; Covino, E; Menna, P; Minotti, G; Paz, OG; Salvatorelli, E; Singer, JW	1

Other Studies

1 other study(ies) available for adriamycinol and pixantrone

Article	Year
The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:2 Topics: Aged; Antibiotics, Antineoplastic; Biotransformation; Chromatography, High Pressure Liquid; Doxorubicin; Drug Synergism; Female; Heart; Humans; Hydrogen Peroxide; In Vitro Techniques; Isoquinolines; Male; Mitoxantrone; Molecular Structure; Myocardium; Oxidation-Reduction; Superoxides	2013

Article

Year

The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients.

The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:2

Topics: Aged; Antibiotics, Antineoplastic; Biotransformation; Chromatography, High Pressure Liquid; Doxorubicin; Drug Synergism; Female; Heart; Humans; Hydrogen Peroxide; In Vitro Techniques; Isoquinolines; Male; Mitoxantrone; Molecular Structure; Myocardium; Oxidation-Reduction; Superoxides

2013